[1]
G. Gancitano, R. Ravasio, L. Cattelino, P. Di Procolo, and D. Cortinovis, “Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer”, FE, vol. 21, no. 1, Feb. 2020.